Download PDF
Klin Monbl Augenheilkd 2023; 240(09): 1060-1070
DOI: 10.1055/a-2108-6758
Übersicht

Diabetic Retinopathy – a Common Disease

Article in several languages: English | deutsch

Authors

  • Georg Spital

    1   Augenzentrum am St. Franziskus-Hospital, Münster, Deutschland

  • Henrik Faatz

    1   Augenzentrum am St. Franziskus-Hospital, Münster, Deutschland
    2   Achim-Wessing-Institut für Ophthalmologische Bildgebung, Universität Essen, Deutschland
Further Information
Also available at
   Permissions and Reprints
Preview

Abstract

Diabetic retinopathy (DR) is one of the most common complications of diabetes mellitus and one of the leading causes of visual impairment in working age individuals in the western world. The treatment of DR depends on its severity, so it is of great importance to detect patients as early as possible, in order to initiate early treatment and preserve vision. Despite currently insufficient screening participation, patients with diabetes already visit ophthalmological practices and clinics above average. Their medical care, including DR diagnostics and treatment has been making up an increasing proportion of ophthalmic activity for years. Since the prevalence of diabetes is increasing dramatically worldwide and a further increase is also predicted for Germany, the challenge for ophthalmologists is likely to grow considerably. As the same time, the diagnostic possibilities for differentiating DR and the therapeutic measures, especially with IVOM therapy, are becoming more and more complex, which increases the time burden in everyday clinical practice. The hope to avoid healthcare deficits and to further improve screening rates and visual acuity prognosis in patients with DR is based, among other things, on camera-assisted screening supported by artificial intelligence. Better diabetes management to reduce the prevalence of DR, as well as longer-acting drugs to treat DR, could also improve the care and help reduce the burden on ophthalmology practices.

Key words

diabetic retinopathy - diabetic macular edema - screening examination - diabetes mellitus


Publication History

Received: 11 May 2023

Accepted: 19 May 2023

Article published online:
04 September 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References/Literatur

  • 1 Saeedi P, Petersohn I, Salpea P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019; 157: 107843
    Search in Google Scholar
  • 2 Ogurtsova K, Guariguata L, Barengo NC. et al. IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract 2022; 183: 109118
    Search in Google Scholar
  • 3 Diaz-Valencia PA, Bougnères P, Valleron AJ. Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health 2015; 15: 255
    Search in Google Scholar
  • 4 Tuomi T, Groop LC, Zimmet PZ. et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42: 359-362
    Search in Google Scholar
  • 5 Ahlqvist E, Storm P, Käräjämäki A. et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018; 6: 361-369
    Search in Google Scholar
  • 6 Ponto KA, Koenig J, Peto T. et al. Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS). Diabetologia 2016; 59: 1913-1919
    Search in Google Scholar
  • 7 Schuster AK, Wolfram C, Pfeiffer N. et al. Augenheilkunde 2019 – Wo stehen wir?. Ophthalmologe 2019; 116: 829-837
    Search in Google Scholar
  • 8 Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 2568-2569
    Search in Google Scholar
  • 9 World Health Organization (WHO). TADDS: tool for the assessment of diabetic retinopathy and diabetes management systems. Im Internet (Stand: 17.04.2023): https://www.who.int/publications/i/item/tadds-tool-for-the-assessment-of-diabetic-retinopathy-and-diabetes-management-systems
  • 10 Hainsworth DP, Bebu I, Aiello LP. et al. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care 2019; 42: 875-882
    Search in Google Scholar
  • 11 Basina M, Maahs DM. Age at type 1 diabetes onset: a new risk factor and call for focused treatment. The Lancet 2018; 392: 453-454
    Search in Google Scholar
  • 12 Teo ZL, Tham YC, Yu M. et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology 2021; 128: 1580-1591
    Search in Google Scholar
  • 13 Li JQ, Welchowski T, Schmid M. et al. Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis. Eur J Epidemiol 2020; 35: 11-23
    Search in Google Scholar
  • 14 Teo ZL, Tham YC, Yu M. et al. Do we have enough ophthalmologists to manage vision-threatening diabetic retinopathy? A global perspective. Eye (Lond) 2020; 34: 1255-1261
    Search in Google Scholar
  • 15 Hristova E, Koseva D, Zlatarova Z. et al. Diabetic Retinopathy Screening and Registration in Europe-Narrative Review. Healthcare (Basel) 2021; 9: 745
    Search in Google Scholar
  • 16 Schmidt C, Reitzle L, Dreß J. et al. [Prevalence and incidence of documented diabetes based on health claims data-reference analysis for diabetes surveillance in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020; 63: 93-102
    Search in Google Scholar
  • 17 Hesse L, Grüsser M, Hoffstadt K. et al. [Population-based study of diabetic retinopathy in Wolfsburg]. Ophthalmologe 2001; 98: 1065-1068
    Search in Google Scholar
  • 18 Hammes HP, Welp R, Kempe HP. et al. Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database. PLoS One 2015; 10: e0132492
    Search in Google Scholar
  • 19 Hammes HP, Kerner W, Hofer S. et al. Diabetic retinopathy in type 1 diabetes – a contemporary analysis of 8,784 patients. Diabetologia 2011; 54: 1977-1984
    Search in Google Scholar
  • 20 Groos S, Kretschmann J, Weber A. et al. Qualitätsbericht 2021: Disease-Management-Programme in Nordrhein. Im Internet (Stand: 17.07.2023): https://www.kgnw.de/service/dmp/dmp-nordrhein-qualitaetsbericht-2021
  • 21 Blum M, Kloos C, Müller N. et al. [Prevalence of diabetic retinopathy. Check-up program of a public health insurance company in Germany 2002–2004]. Ophthalmologe 2007; 104: 499-500 502–504
    Search in Google Scholar
  • 22 Huppertz E, Pieper L, Klotsche J. et al. Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled – results of the DETECT study. Exp Clin Endocrinol Diabetes 2009; 117: 6-14
    Search in Google Scholar
  • 23 Heller T, Blum M, Spraul M. et al. [Diabetic co-morbidities: prevalences in Germany]. Dtsch Med Wochenschr 2014; 139: 786-791
    Search in Google Scholar
  • 24 Goffrier B, Schulz M, Bätzing-Feigenbaum J. Administrative Prävalenzen und Inzidenzen des Diabetes mellitus von 2009 bis 2015. Versorgungsatlas-Bericht Nr. 17/03. 23.02.2017. Im Internet (Stand: 17.07.2023): https://www.versorgungsatlas.de/themen/alle-analysen-nach-datum-sortiert/?tab=6&uid=79
  • 25 Wilke RGH, Finger RP, Sachs HG. [Real-life Data on the Treatment of Diabetic Macular Oedema in Germany]. Klin Monbl Augenheilkd 2017; 234: 1502-1507
    Search in Google Scholar
  • 26 Stefanickova J, Cunha-Vaz J, Ulbig M. et al. A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS). Acta Ophthalmol 2018; 96: e942-e949
    Search in Google Scholar
  • 27 Faatz H, Rothaus K, Westhues D. et al. [Treatment adherence and effectiveness of anti-Vascular Endothelial Growth Faktor (VEGF) treatment of diabetic macular edema in the clinical routine: Comparison between cooperative and unicentric organization of treatment]. Ophthalmologe 2020; 117: 557-565
    Search in Google Scholar
  • 28 Finger RP, Fimmers R, Holz FG. et al. Incidence of blindness and severe visual impairment in Germany: projections for 2030. Invest Ophthalmol Vis Sci 2011; 52: 4381-4389
    Search in Google Scholar
  • 29 Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med 2012; 366: 1227-1239
    Search in Google Scholar
  • 30 Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol 2021; 17: 195-206
    Search in Google Scholar
  • 31 Yau JWY, Rogers SL, Kawasaki R. et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35: 556-564
    Search in Google Scholar
  • 32 Lachin JM, Genuth S, Nathan DM. et al. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial–revisited. Diabetes 2008; 57: 995-1001
    Search in Google Scholar
  • 33 Zhao M, Gelize E, Levy R. et al. Mineralocorticoid Receptor Pathway and Its Antagonism in a Model of Diabetic Retinopathy. Diabetes 2021; 70: 2668-2682
    Search in Google Scholar
  • 34 Reid LJ, Gibb FW, Colhoun H. et al. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin. Diabetologia 2021; 64: 1725-1736
    Search in Google Scholar
  • 35 Zhang P, Kumar A, Katz LS. et al. Induction of the ChREBPβ Isoform Is Essential for Glucose-Stimulated β-Cell Proliferation. Diabetes 2015; 64: 4158-4170
    Search in Google Scholar
  • 36 Do DV, Han G, Abariga SA. et al. Blood pressure control for diabetic retinopathy. Cochrane Database Syst Rev 2023; (03) CD006127
    Search in Google Scholar
  • 37 Keech AC, Mitchell P, Summanen PA. et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007; 370: 1687-1697
    Search in Google Scholar
  • 38 Meer E, Bavinger JC, Yu Y. et al. Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy. JAMA Ophthalmol 2022; 140: 529-532
    Search in Google Scholar
  • 39 Li Y, Su X, Ye Q. et al. The predictive value of diabetic retinopathy on subsequent diabetic nephropathy in patients with type 2 diabetes: a systematic review and meta-analysis of prospective studies. Ren Fail 2021; 43: 231-240
    Search in Google Scholar
  • 40 Cosentino F, Grant PJ, Aboyans V. et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020; 41: 255-323
    Search in Google Scholar
  • 41 Ziemssen F, Lemmen K, Bertram B. et al. [National guidelines for treatment of diabetic retinopathy: Second edition of the national guidelines for treatment of diabetic retinopathy]. Ophthalmologe 2016; 113: 623-638
    Search in Google Scholar
  • 42 Wang J, Xin X, Luo W. et al. Anemia and Diabetic Kidney Disease Had Joint Effect on Diabetic Retinopathy Among Patients With Type 2 Diabetes. Invest Ophthalmol Vis Sci 2020; 61: 25
    Search in Google Scholar
  • 43 [Anonymous] Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991; 98 (5 Suppl): 766-785
    Search in Google Scholar
  • 44 Writing Committee for the Diabetic Retinopathy Clinical Research Network. Fong DS, Strauber SF, Aiello LP. et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 2007; 125: 469-480
    Search in Google Scholar
  • 45 [Anonymous] Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 1985; 103: 1796-1806
    Search in Google Scholar
  • 46 Zhang X, Saaddine JB, Chou CF. et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010; 304: 649-656
    Search in Google Scholar
  • 47 Claessen H, Kvitkina T, Narres M. et al. Markedly Decreasing Incidence of Blindness in People With and Without Diabetes in Southern Germany. Diabetes Care 2018; 41: 478-484
    Search in Google Scholar
  • 48 Scanlon PH. The English National Screening Programme for diabetic retinopathy 2003–2016. Acta Diabetol 2017; 54: 515-525
    Search in Google Scholar
  • 49 Bertram B, Gante C, Hilgers RD. [Increase in examinations for cataracts, glaucoma, diabetic retinopathy and age-related macular degeneration: Comparative cross-sectional study between 2010 and 1997 in ophthalmological practices]. Ophthalmologe 2014; 111: 757-764
    Search in Google Scholar
  • 50 Schuster AK, Wolfram C, Pfeiffer N. et al. [Ophthalmology 2019-where do we stand?: An analysis of the treatment situation in Germany]. Ophthalmologe 2019; 116: 829-837
    Search in Google Scholar
  • 51 Schuster AK, Wolfram C, Bertram B. et al. [Who visits an ophthalmologist and how often? Results of the German nationwide adult health survey (DEGS1)]. Ophthalmologe 2018; 115: 1042-1049
    Search in Google Scholar
  • 52 Kreft D, McGuinness MB, Doblhammer G. et al. Diabetic retinopathy screening in incident diabetes mellitus type 2 in Germany between 2004 and 2013 – A prospective cohort study based on health claims data. PLoS One 2018; 13: e0195426
    Search in Google Scholar
  • 53 Baumeister SE, Schomerus G, Andersen RM. et al. Trends of barriers to eye care among adults with diagnosed diabetes in Germany, 1997–2012. Nutr Metab Cardiovasc Dis 2015; 25: 906-915
    Search in Google Scholar
  • 54 Wenzel M, Schayan K, Wirbelauer C. et al. Ambulante und stationäre Intraokularchirurgie 2020/21: Ergebnisse der aktuellen Umfrage im Corona-Jahr von BDOC, BVA, DGII und DOG. Im Internet (Stand: 17.07.2023): http://bdoc.info/dl/aktuelles_ambulante-intraokularchirurgie_wenzel-et-al-umfrage-2020.pdf
  • 55 Wenzel M, Kohnen T, Scharrer A. et al. Umfrage von DGII, BVA und BDOC zur ambulanten Intraokularchirurgie 2009. 2010. Im Internet (Stand: 17.07.2023): https://www.dgii.org/uploads/jahresband/2010/Wenzel.pdf
  • 56 König SF, Spital G, Ziemssen F. et al. [Photo-based examination for diabetic eye pathologies in a German ophthalmological practice without personal doctor-patient contact]. Ophthalmologie 2023; 120: 301-308
    Search in Google Scholar
  • 57 Paul S, Tayar A, Morawiec-Kisiel E. et al. [Use of artificial intelligence in screening for diabetic retinopathy at a tertiary diabetes center]. Ophthalmologie 2022; 119: 705-713
    Search in Google Scholar
  • 58 Stebbins K, Kieltyka S, Chaum E. Follow-Up Compliance for Patients Diagnosed with Diabetic Retinopathy After Teleretinal Imaging in Primary Care. Telemed J E Health 2021; 27: 303-307
    Search in Google Scholar
  • 59 Channa R, Wolf RM, Abràmoff MD. et al. Effectiveness of artificial intelligence screening in preventing vision loss from diabetes: a policy model. NPJ Digit Med 2023; 6: 53
    Search in Google Scholar
  • 60 Rajalakshmi R, Subashini R, Anjana RM. et al. Automated diabetic retinopathy detection in smartphone-based fundus photography using artificial intelligence. Eye (Lond) 2018; 32: 1138-1144
    Search in Google Scholar
  • 61 Kumari S, Venkatesh P, Tandon N. et al. Selfie fundus imaging for diabetic retinopathy screening. Eye (Lond) 2022; 36: 1988-1993
    Search in Google Scholar
  • 62 Ryu G, Lee K, Park D. et al. A deep learning model for identifying diabetic retinopathy using optical coherence tomography angiography. Sci Rep 2021; 11: 23024
    Search in Google Scholar
  • 63 Maturi RK, Glassman AR, Josic K. et al. Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs. Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial. JAMA Ophthalmol 2021; 139: 701-712
    Search in Google Scholar